GLP-1 (glucagon-like peptide-1) receptor agonists have emerged as one of the most significant breakthroughs in weight loss treatment in decades. Originally developed for type 2 diabetes management, these medications have shown remarkable effectiveness for sustainable weight loss.
How GLP-1 Medications Work
GLP-1 is a naturally occurring hormone in your body that plays several important roles:
GLP-1 receptor agonist medications mimic this natural hormone, amplifying its effects. The result? Reduced appetite, fewer cravings, and meaningful weight loss.
Clinical Results
Clinical trials have shown impressive results with GLP-1 medications:
Who Is a Good Candidate?
GLP-1 treatment may be appropriate if you:
Getting Started
At Majesta Health, we make accessing GLP-1 treatment simple. Start your 2-minute medical assessment, connect with a licensed physician, and, if approved, have your medication delivered to your door.
The first step is understanding your options. The second step is taking action.
<!-- related-2026-injected -->
Related 2026 guides
All Majesta Health medical content is clinically reviewed before publication by US-licensed physicians affiliated with our clinical infrastructure partner, MD Integrations (MDI). Reviewers hold active state medical licenses, are board-certified in primary care or obesity medicine, and specialize in GLP-1 receptor agonist therapy for chronic weight management. MDI is LegitScript certified and SOC 2 Type II accredited.
- US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
- Board-certified in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across all 50 US states and DC through the MD Integrations Medical Services Organization
- Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited, 503A and 503B compounding)